Eli Lilly and Co. (NYSE:LLY) on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial ...

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance ...

When a Honolulu police officer fires a gun or someone is badly hurt or killed, the moment does not end at the scene. It ...

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

The Pakistan Stock Exchange (PSX) extended its downturn on Tuesday, with the benchmark KSE‑100 index falling 1,303.52 points ...

Trading at the Pakistan Stock Exchange (PSX) kicked off on a positive note, with the benchmark KSE-100 Index gaining over 700 points during the opening minutes of trading on Wednesday. At 9:35am, the ...

Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and overweight or obesity, according to topline results announced by Eli ...

Trading kicked off at the Pakistan Stock Exchange (PSX) on a positive note amid days of selling pressure, with the benchmark KSE-100 Index gaining nearly 1,900 points during the opening minutes of ...

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

Norwegian Air Shuttle ASA ( NWARF) Q4 2025 Earnings Call February 13, 2026 2:30 AM EST ...

Many of the professionals associated with Freiburg weren’t involved in the 2022 DFB Pokal Final shootout at Berlin’s Olympiastadion. That didn’t necessarily mean there wasn’t a sense of deja ...

American Electric Power Company, Inc. ( AEP) Q4 2025 Earnings Call February 12, 2026 9:00 AM EST Thank you for standing by. My name is Carly, and I will be your conference operator today. At this time ...